Provided by Tiger Fintech (Singapore) Pte. Ltd.

Portage Biotech Inc.

8.88
+0.29003.38%
Post-market: 8.21-0.6655-7.49%19:59 EDT
Volume:796.36K
Turnover:6.76M
Market Cap:14.61M
PE:-0.14
High:9.72
Open:8.70
Low:7.11
Close:8.59
Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Wells Fargo, American Express, Mondelez

Reuters
·
12 Apr

Portage Biotech trading resumes

TIPRANKS
·
11 Apr

Portage Biotech trading halted, volatility trading pause

TIPRANKS
·
11 Apr

Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher

Benzinga
·
29 Mar

Top Premarket Gainers

MT Newswires Live
·
28 Mar

Investors Await Key Inflation Data as US Futures Decline Pre-Bell

MT Newswires Live
·
28 Mar

Portage Biotech Shares More Than Double After Results of PORT-7 Tumor Treatment Trial

Dow Jones
·
28 Mar

Portage Reports 'Promising' Preclinical Results in Mesothelioma

MT Newswires Live
·
28 Mar

BRIEF-Portage Biotech Reports Promising Preclinical Results In Mesothelioma Supporting First-In-Human Trial Of Port-7

Reuters
·
28 Mar

Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-in-Human Trial of Port-7

THOMSON REUTERS
·
28 Mar

Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

GlobeNewswire
·
28 Mar

Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

THOMSON REUTERS
·
13 Feb

Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

GlobeNewswire
·
13 Feb

Portage Biotech Announces Completion of $2.15 Million Private Financing

THOMSON REUTERS
·
31 Jan

Press Release: Portage Biotech Announces Completion of $2.15 Million Private Financing

Dow Jones
·
31 Jan

BRIEF-Portage Biotech Re-Launches Adenosine Unit As Independently Managed Co

Reuters
·
06 Jan

Portage Biotech: Re-Launches Adenosine Unit as Independently Managed Co

THOMSON REUTERS
·
06 Jan

Portage Biotech: Peter Molloy Has Been Appointed CEO of Unit, to Be Named Cyncado Therapeutics, Inc

THOMSON REUTERS
·
06 Jan

Portage announces relaunch of adenosine subsidiary as independently managed

TIPRANKS
·
06 Jan

Press Release: Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company

Dow Jones
·
06 Jan